Deal Details

Softbox Sold to Csafe

---

Summary

About

Softbox, founded in 1995, is a leading global innovator and provider of passive temperature-controlled packaging solutions. The Company offers consistent quality to its clients from its strategically located global manufacturing sites throughout EMEA, North America, Latin America, India and Asia Pacific. Softbox has formed long-standing partnerships with the world’s leading biotech, pharmaceutical, clinical research and third-party logistics companies and applies innovative thinking to overcome the challenges that its clients face in managing the cold chain when shipping temperature-sensitive clinical trial and commercialised products. The critical importance of temperature-controlled packaging was highlighted over the last two years due to the temperature-controlled packaging requirements of mRNA COVID-19 vaccines. Softbox was and continues to be a primary supplier for COVID-19 vaccine temperature-controlled shipping needs. The Company is based in Long Crendon, the United Kingdom.

Great Point Partners, founded in 2003, is a leading healthcare investment firm with 30 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new minority and majority private equity investments from GPP III, which has $307 million of committed capital. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital and GPP III, $307 million) and public life sciences equity fund (BioMedical Value Fund). Since its inception, GPP has provided growth equity, growth recapitalisation and management buyout financing to more than 200 growing healthcare companies. The firm invests across all sectors of the healthcare industry with a particular emphasis on biopharmaceutical services and supplies, alternate site care, medical device and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. GPP is based in Greenwich, Connecticut.

CSafe Global, founded in 1979, is a leading provider of end-to-end thermal shipping solutions to the pharmaceutical and life science industries worldwide. An industry innovator, CSafe is the only provider of both active and passive solutions and offers AI-enabled lease forecasting to ensure active container availability and real-time shipment visibility for active and passive containers. CSafe provides industry-leading maintenance and reuse programs ensuring superior product performance and alignment with customer sustainability objectives. With a presence in 150 countries, 24/7 support and 100% container availability, CSafe is well-positioned to be the partner of choice in the cold chain. CSafe is based in Dayton, Ohio.

Frazier Healthcare Partners, founded in 1991, is a leading provider of growth and venture capital to healthcare companies. With over $7 billion in total capital raised, Frazier has invested in more than 200 companies with transaction types ranging from buyouts of profitable healthcare services companies to venture capital and company creation. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier has offices in Seattle, Washington, and Menlo Park, California, and invests broadly across the United States, Canada and Europe.

Thomas H. Lee Partners is a premier private equity firm investing in middle-market growth companies exclusively in three sectors: Financial Services, Healthcare and Technology & Business Solutions. THL couples deep sector expertise through its Identified Sector Opportunity (“ISO”) process with dedicated internal operating resources from its Strategic Resource Group (“SRG”) to transform and build great companies of lasting value in partnership with management. The firm's domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. Since 1974, THL has raised more than $30 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion.

---

CONTACT US TO LEARN MORE